<?xml version="1.0" encoding="UTF-8"?><rss xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:content="http://purl.org/rss/1.0/modules/content/" xmlns:atom="http://www.w3.org/2005/Atom" version="2.0"><channel><title><![CDATA[SashaStafford.com]]></title><description><![CDATA[Sasha Stafford is a professional specializing in the development of novel drug delivery technologies. The focus of his business is on providing quality technical consultation to clients. With a commitment to both patients and stakeholders, Sasha aims to develop new technologies to reduce patient suffering while increasing patient compliance.]]></description><link>https://www.sashastafford.com/blog</link><generator>RSS for Node</generator><lastBuildDate>Sun, 26 Apr 2026 07:27:23 GMT</lastBuildDate><atom:link href="https://www.sashastafford.com/blog-feed.xml" rel="self" type="application/rss+xml"/><item><title><![CDATA[Modular Vaccine Technology for Known and Unknown Diseases ]]></title><description><![CDATA[An animation to accompany our "Modular biomaterials vaccine technology protects against multiple pathogens and septic shock" paper, where we describe the development of ciVAX (Composite Infection Vaccine), a modular, injectable biomaterial scaffold designed to provide broad-spectrum protection against lethal bacterial infections and sepsis. Full report @ https://is.gd/CzSnuk #sepsis #vaccines #Biomaterials #medtech #science #publichealth #pathogenX #pandemics]]></description><link>https://www.sashastafford.com/post/modular-vaccine-technology-for-known-and-unknown-diseases</link><guid isPermaLink="false">69e4656d0c8d230c9e918b70</guid><pubDate>Tue, 21 Apr 2026 16:00:29 GMT</pubDate><enclosure url="http://video.wixstatic.com/video/3a0e66_5ca59932c310492abd38db31544abe7d/1080p/mp4/file.mp4" length="0" type="video"/><dc:creator>Sasha Stafford</dc:creator></item><item><title><![CDATA[Modular Vaccine Platform Against Pathogen X]]></title><description><![CDATA[Our "Modular biomaterials vaccine technology protects against multiple pathogens and septic shock" paper describes the development of ciVAX (Composite Infection Vaccine), a modular, injectable biomaterial scaffold designed to provide broad-spectrum protection against lethal bacterial infections and sepsis. Full report @ https://is.gd/CzSnuk #sepsis #vaccines #Biomaterials #medtech #science #publichealth #pathogenX #pandemics  Core Technology: How ciVAX Works The vaccine is not a traditional...]]></description><link>https://www.sashastafford.com/post/modular-vaccine-platform-against-pathogen-x</link><guid isPermaLink="false">69d9154175afb0779a6f3c89</guid><pubDate>Fri, 10 Apr 2026 15:32:41 GMT</pubDate><enclosure url="https://static.wixstatic.com/media/3a0e66_c4c91da809ae452a936b18a7ac1a534c~mv2.jpeg/v1/fit/w_1000,h_936,al_c,q_80/file.png" length="0" type="image/png"/><dc:creator>Sasha Stafford</dc:creator></item><item><title><![CDATA[Artificial Bone Marrow Niche ]]></title><description><![CDATA[Our recently published article entitled "Kinetics of De Novo Bone and Bone Marrow Niche Formation With Hybrid Click Cryogels", explores strategies to rebuild the bone marrow environment to improve the success of hematopoietic stem cell transplantation (HSCT). Full report @ https://is.gd/1tleYm Main Objective The study addresses the problem of damaged bone marrow niches following irradiation, which often leads to delayed immune reconstitution and HSCT failure. The researchers developed a...]]></description><link>https://www.sashastafford.com/post/artificial-bone-marrow-niche</link><guid isPermaLink="false">69c2f354149f4fed564fee14</guid><pubDate>Tue, 24 Mar 2026 21:08:58 GMT</pubDate><enclosure url="https://static.wixstatic.com/media/3a0e66_92fa381b7c38488fb1fc1a14fc00f598~mv2.jpeg/v1/fit/w_360,h_360,al_c,q_80/file.png" length="0" type="image/png"/><dc:creator>Sasha Stafford</dc:creator></item></channel></rss>